CRISPR Therapeutics AG Profile Avatar - Palmy Investing

CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRIS…

Biotechnology
CH, Zug [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of CRSP's Analysis
CIK: 1674416 CUSIP: H17182108 ISIN: CH0334081137 LEI: - UEI: -
Secondary Listings
CRSP has no secondary listings inside our databases.